SALT LAKE CITY, UT--(MARKET WIRE)--Aug 8, 2007 -- Myriad Genetics, Inc. (NasdaqGS:MYGN - News) has arranged a conference call with the management team to provide a company update. Peter D. Meldrum, President and Chief Executive Officer, will host the call along with Jay M. Moyes, Chief Financial Officer, Mark Skolnick, Ph.D., Chief Scientific Officer, Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., and Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
